nodes	percent_of_prediction	percent_of_DWPC	metapath
Mepenzolate—Urinary retention—Ibandronate—osteoporosis	0.0149	0.0152	CcSEcCtD
Mepenzolate—Confusional state—Calcium Acetate—osteoporosis	0.0142	0.0145	CcSEcCtD
Mepenzolate—Abdominal distension—Estropipate—osteoporosis	0.0142	0.0145	CcSEcCtD
Mepenzolate—Abdominal distension—Alendronate—osteoporosis	0.014	0.0143	CcSEcCtD
Mepenzolate—Loperamide—POMC—osteoporosis	0.0139	0.63	CrCbGaD
Mepenzolate—Constipation—Calcium Acetate—osteoporosis	0.0121	0.0123	CcSEcCtD
Mepenzolate—Drowsiness—Calcitriol—osteoporosis	0.0118	0.012	CcSEcCtD
Mepenzolate—Feeling abnormal—Calcium Acetate—osteoporosis	0.0116	0.0119	CcSEcCtD
Mepenzolate—Abdominal distension—Ethinyl Estradiol—osteoporosis	0.0115	0.0117	CcSEcCtD
Mepenzolate—Abdominal distension—Risedronate—osteoporosis	0.0112	0.0115	CcSEcCtD
Mepenzolate—Constipation—Ergocalciferol—osteoporosis	0.0106	0.0109	CcSEcCtD
Mepenzolate—Hypersensitivity—Calcium Acetate—osteoporosis	0.0104	0.0106	CcSEcCtD
Mepenzolate—Asthenia—Calcium Acetate—osteoporosis	0.0101	0.0103	CcSEcCtD
Mepenzolate—Abdominal distension—Zoledronate—osteoporosis	0.00973	0.00994	CcSEcCtD
Mepenzolate—Tension—Estropipate—osteoporosis	0.00963	0.00984	CcSEcCtD
Mepenzolate—Nervousness—Estropipate—osteoporosis	0.00953	0.00974	CcSEcCtD
Mepenzolate—Abdominal distension—Conjugated Estrogens—osteoporosis	0.00936	0.00958	CcSEcCtD
Mepenzolate—Confusional state—Etidronic acid—osteoporosis	0.00933	0.00954	CcSEcCtD
Mepenzolate—Dizziness—Calcium Acetate—osteoporosis	0.00932	0.00953	CcSEcCtD
Mepenzolate—Vomiting—Calcium Acetate—osteoporosis	0.00896	0.00916	CcSEcCtD
Mepenzolate—Asthenia—Ergocalciferol—osteoporosis	0.00893	0.00913	CcSEcCtD
Mepenzolate—Palpitations—Estropipate—osteoporosis	0.00867	0.00886	CcSEcCtD
Mepenzolate—Nausea—Calcium Acetate—osteoporosis	0.00837	0.00856	CcSEcCtD
Mepenzolate—Palpitations—Ibandronate—osteoporosis	0.00831	0.0085	CcSEcCtD
Mepenzolate—Anaphylactic shock—Estropipate—osteoporosis	0.00801	0.00819	CcSEcCtD
Mepenzolate—Constipation—Etidronic acid—osteoporosis	0.00791	0.00809	CcSEcCtD
Mepenzolate—Dry mouth—Ibandronate—osteoporosis	0.00783	0.00801	CcSEcCtD
Mepenzolate—Anaphylactic shock—Ibandronate—osteoporosis	0.00768	0.00785	CcSEcCtD
Mepenzolate—Dry mouth—Calcitriol—osteoporosis	0.00767	0.00784	CcSEcCtD
Mepenzolate—Feeling abnormal—Etidronic acid—osteoporosis	0.00763	0.0078	CcSEcCtD
Mepenzolate—Anaphylactic shock—Calcitriol—osteoporosis	0.00752	0.00768	CcSEcCtD
Mepenzolate—Abdominal distension—Estradiol—osteoporosis	0.00749	0.00766	CcSEcCtD
Mepenzolate—Nausea—Ergocalciferol—osteoporosis	0.0074	0.00756	CcSEcCtD
Mepenzolate—Urticaria—Etidronic acid—osteoporosis	0.00735	0.00752	CcSEcCtD
Mepenzolate—Insomnia—Estropipate—osteoporosis	0.00724	0.0074	CcSEcCtD
Mepenzolate—Tension—Pamidronate—osteoporosis	0.00723	0.00739	CcSEcCtD
Mepenzolate—Nervousness—Pamidronate—osteoporosis	0.00716	0.00732	CcSEcCtD
Mepenzolate—Somnolence—Estropipate—osteoporosis	0.00712	0.00728	CcSEcCtD
Mepenzolate—Insomnia—Raloxifene—osteoporosis	0.00701	0.00717	CcSEcCtD
Mepenzolate—Insomnia—Ibandronate—osteoporosis	0.00694	0.0071	CcSEcCtD
Mepenzolate—Constipation—Estropipate—osteoporosis	0.00685	0.007	CcSEcCtD
Mepenzolate—Hypersensitivity—Etidronic acid—osteoporosis	0.00682	0.00697	CcSEcCtD
Mepenzolate—Insomnia—Calcitriol—osteoporosis	0.0068	0.00695	CcSEcCtD
Mepenzolate—Constipation—Alendronate—osteoporosis	0.00674	0.0069	CcSEcCtD
Mepenzolate—Somnolence—Calcitriol—osteoporosis	0.00668	0.00683	CcSEcCtD
Mepenzolate—Constipation—Ibandronate—osteoporosis	0.00656	0.00671	CcSEcCtD
Mepenzolate—Feeling abnormal—Alendronate—osteoporosis	0.0065	0.00664	CcSEcCtD
Mepenzolate—Dry mouth—Risedronate—osteoporosis	0.00645	0.0066	CcSEcCtD
Mepenzolate—Constipation—Calcitriol—osteoporosis	0.00643	0.00657	CcSEcCtD
Mepenzolate—Tension—Conjugated Estrogens—osteoporosis	0.00636	0.0065	CcSEcCtD
Mepenzolate—Urticaria—Estropipate—osteoporosis	0.00636	0.0065	CcSEcCtD
Mepenzolate—Vision blurred—Zoledronate—osteoporosis	0.00634	0.00649	CcSEcCtD
Mepenzolate—Feeling abnormal—Ibandronate—osteoporosis	0.00633	0.00647	CcSEcCtD
Mepenzolate—Nervousness—Conjugated Estrogens—osteoporosis	0.0063	0.00644	CcSEcCtD
Mepenzolate—Urticaria—Alendronate—osteoporosis	0.00626	0.00641	CcSEcCtD
Mepenzolate—Vision blurred—Conjugated Estrogens—osteoporosis	0.00611	0.00625	CcSEcCtD
Mepenzolate—Urticaria—Ibandronate—osteoporosis	0.0061	0.00624	CcSEcCtD
Mepenzolate—Confusional state—Pamidronate—osteoporosis	0.00606	0.0062	CcSEcCtD
Mepenzolate—Anaphylactic shock—Pamidronate—osteoporosis	0.00601	0.00615	CcSEcCtD
Mepenzolate—Urticaria—Calcitriol—osteoporosis	0.00597	0.0061	CcSEcCtD
Mepenzolate—Palpitations—Zoledronate—osteoporosis	0.00595	0.00608	CcSEcCtD
Mepenzolate—Hypersensitivity—Estropipate—osteoporosis	0.0059	0.00603	CcSEcCtD
Mepenzolate—Vomiting—Etidronic acid—osteoporosis	0.00588	0.00602	CcSEcCtD
Mepenzolate—Tachycardia—Pamidronate—osteoporosis	0.00587	0.006	CcSEcCtD
Mepenzolate—Hypersensitivity—Alendronate—osteoporosis	0.00581	0.00594	CcSEcCtD
Mepenzolate—Headache—Etidronic acid—osteoporosis	0.0058	0.00593	CcSEcCtD
Mepenzolate—Asthenia—Estropipate—osteoporosis	0.00574	0.00587	CcSEcCtD
Mepenzolate—Palpitations—Conjugated Estrogens—osteoporosis	0.00573	0.00586	CcSEcCtD
Mepenzolate—Insomnia—Risedronate—osteoporosis	0.00572	0.00585	CcSEcCtD
Mepenzolate—Asthenia—Alendronate—osteoporosis	0.00566	0.00579	CcSEcCtD
Mepenzolate—Hypersensitivity—Ibandronate—osteoporosis	0.00566	0.00578	CcSEcCtD
Mepenzolate—Dry mouth—Zoledronate—osteoporosis	0.0056	0.00573	CcSEcCtD
Mepenzolate—Constipation—Ethinyl Estradiol—osteoporosis	0.00555	0.00567	CcSEcCtD
Mepenzolate—Confusional state—Zoledronate—osteoporosis	0.00554	0.00566	CcSEcCtD
Mepenzolate—Hypersensitivity—Calcitriol—osteoporosis	0.00554	0.00566	CcSEcCtD
Mepenzolate—Asthenia—Ibandronate—osteoporosis	0.00551	0.00563	CcSEcCtD
Mepenzolate—Nausea—Etidronic acid—osteoporosis	0.0055	0.00562	CcSEcCtD
Mepenzolate—Anaphylactic shock—Zoledronate—osteoporosis	0.00549	0.00562	CcSEcCtD
Mepenzolate—Insomnia—Pamidronate—osteoporosis	0.00544	0.00556	CcSEcCtD
Mepenzolate—Constipation—Risedronate—osteoporosis	0.00541	0.00553	CcSEcCtD
Mepenzolate—Asthenia—Calcitriol—osteoporosis	0.00539	0.00551	CcSEcCtD
Mepenzolate—Tachycardia—Zoledronate—osteoporosis	0.00536	0.00548	CcSEcCtD
Mepenzolate—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.00535	0.00547	CcSEcCtD
Mepenzolate—Somnolence—Pamidronate—osteoporosis	0.00535	0.00547	CcSEcCtD
Mepenzolate—Dizziness—Estropipate—osteoporosis	0.00529	0.00541	CcSEcCtD
Mepenzolate—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.00529	0.00541	CcSEcCtD
Mepenzolate—Dizziness—Alendronate—osteoporosis	0.00521	0.00533	CcSEcCtD
Mepenzolate—Tachycardia—Conjugated Estrogens—osteoporosis	0.00516	0.00528	CcSEcCtD
Mepenzolate—Urticaria—Ethinyl Estradiol—osteoporosis	0.00516	0.00527	CcSEcCtD
Mepenzolate—Levomethadyl Acetate—CYP19A1—osteoporosis	0.00515	0.233	CrCbGaD
Mepenzolate—Constipation—Pamidronate—osteoporosis	0.00514	0.00526	CcSEcCtD
Mepenzolate—Dizziness—Raloxifene—osteoporosis	0.00513	0.00524	CcSEcCtD
Mepenzolate—Tension—Estradiol—osteoporosis	0.00509	0.00521	CcSEcCtD
Mepenzolate—Vomiting—Estropipate—osteoporosis	0.00509	0.0052	CcSEcCtD
Mepenzolate—Dizziness—Ibandronate—osteoporosis	0.00508	0.00519	CcSEcCtD
Mepenzolate—Nervousness—Estradiol—osteoporosis	0.00504	0.00515	CcSEcCtD
Mepenzolate—Urticaria—Risedronate—osteoporosis	0.00503	0.00514	CcSEcCtD
Mepenzolate—Headache—Estropipate—osteoporosis	0.00502	0.00513	CcSEcCtD
Mepenzolate—Vomiting—Alendronate—osteoporosis	0.00501	0.00513	CcSEcCtD
Mepenzolate—Insomnia—Zoledronate—osteoporosis	0.00497	0.00508	CcSEcCtD
Mepenzolate—Feeling abnormal—Pamidronate—osteoporosis	0.00496	0.00507	CcSEcCtD
Mepenzolate—Headache—Alendronate—osteoporosis	0.00494	0.00505	CcSEcCtD
Mepenzolate—Vomiting—Raloxifene—osteoporosis	0.00493	0.00504	CcSEcCtD
Mepenzolate—Somnolence—Zoledronate—osteoporosis	0.00488	0.00499	CcSEcCtD
Mepenzolate—Vomiting—Ibandronate—osteoporosis	0.00488	0.00499	CcSEcCtD
Mepenzolate—Headache—Raloxifene—osteoporosis	0.00486	0.00497	CcSEcCtD
Mepenzolate—Headache—Ibandronate—osteoporosis	0.00481	0.00492	CcSEcCtD
Mepenzolate—Insomnia—Conjugated Estrogens—osteoporosis	0.00478	0.00489	CcSEcCtD
Mepenzolate—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.00478	0.00489	CcSEcCtD
Mepenzolate—Vomiting—Calcitriol—osteoporosis	0.00478	0.00489	CcSEcCtD
Mepenzolate—Nausea—Estropipate—osteoporosis	0.00476	0.00486	CcSEcCtD
Mepenzolate—Headache—Calcitriol—osteoporosis	0.00471	0.00481	CcSEcCtD
Mepenzolate—Somnolence—Conjugated Estrogens—osteoporosis	0.0047	0.00481	CcSEcCtD
Mepenzolate—Constipation—Zoledronate—osteoporosis	0.0047	0.0048	CcSEcCtD
Mepenzolate—Nausea—Alendronate—osteoporosis	0.00468	0.00479	CcSEcCtD
Mepenzolate—Hypersensitivity—Risedronate—osteoporosis	0.00466	0.00477	CcSEcCtD
Mepenzolate—Asthenia—Ethinyl Estradiol—osteoporosis	0.00466	0.00476	CcSEcCtD
Mepenzolate—Nausea—Raloxifene—osteoporosis	0.00461	0.00471	CcSEcCtD
Mepenzolate—Palpitations—Estradiol—osteoporosis	0.00458	0.00469	CcSEcCtD
Mepenzolate—Nausea—Ibandronate—osteoporosis	0.00456	0.00466	CcSEcCtD
Mepenzolate—Asthenia—Risedronate—osteoporosis	0.00454	0.00464	CcSEcCtD
Mepenzolate—Feeling abnormal—Zoledronate—osteoporosis	0.00453	0.00463	CcSEcCtD
Mepenzolate—Constipation—Conjugated Estrogens—osteoporosis	0.00452	0.00463	CcSEcCtD
Mepenzolate—Nausea—Calcitriol—osteoporosis	0.00446	0.00456	CcSEcCtD
Mepenzolate—Hypersensitivity—Pamidronate—osteoporosis	0.00443	0.00453	CcSEcCtD
Mepenzolate—Urticaria—Zoledronate—osteoporosis	0.00436	0.00446	CcSEcCtD
Mepenzolate—Dry mouth—Estradiol—osteoporosis	0.00432	0.00442	CcSEcCtD
Mepenzolate—Asthenia—Pamidronate—osteoporosis	0.00432	0.00441	CcSEcCtD
Mepenzolate—Dizziness—Ethinyl Estradiol—osteoporosis	0.00429	0.00439	CcSEcCtD
Mepenzolate—Confusional state—Estradiol—osteoporosis	0.00427	0.00437	CcSEcCtD
Mepenzolate—Anaphylactic shock—Estradiol—osteoporosis	0.00423	0.00433	CcSEcCtD
Mepenzolate—Urticaria—Conjugated Estrogens—osteoporosis	0.0042	0.0043	CcSEcCtD
Mepenzolate—Dizziness—Risedronate—osteoporosis	0.00418	0.00428	CcSEcCtD
Mepenzolate—Tachycardia—Estradiol—osteoporosis	0.00413	0.00423	CcSEcCtD
Mepenzolate—Vomiting—Ethinyl Estradiol—osteoporosis	0.00413	0.00422	CcSEcCtD
Mepenzolate—Headache—Ethinyl Estradiol—osteoporosis	0.00407	0.00416	CcSEcCtD
Mepenzolate—Hypersensitivity—Zoledronate—osteoporosis	0.00405	0.00414	CcSEcCtD
Mepenzolate—Vomiting—Risedronate—osteoporosis	0.00402	0.00411	CcSEcCtD
Mepenzolate—Dizziness—Pamidronate—osteoporosis	0.00398	0.00407	CcSEcCtD
Mepenzolate—Headache—Risedronate—osteoporosis	0.00396	0.00405	CcSEcCtD
Mepenzolate—Asthenia—Zoledronate—osteoporosis	0.00394	0.00403	CcSEcCtD
Mepenzolate—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.0039	0.00399	CcSEcCtD
Mepenzolate—Nausea—Ethinyl Estradiol—osteoporosis	0.00385	0.00394	CcSEcCtD
Mepenzolate—Insomnia—Estradiol—osteoporosis	0.00383	0.00392	CcSEcCtD
Mepenzolate—Vomiting—Pamidronate—osteoporosis	0.00382	0.00391	CcSEcCtD
Mepenzolate—Asthenia—Conjugated Estrogens—osteoporosis	0.0038	0.00388	CcSEcCtD
Mepenzolate—Headache—Pamidronate—osteoporosis	0.00377	0.00385	CcSEcCtD
Mepenzolate—Somnolence—Estradiol—osteoporosis	0.00376	0.00385	CcSEcCtD
Mepenzolate—Nausea—Risedronate—osteoporosis	0.00376	0.00384	CcSEcCtD
Mepenzolate—Dizziness—Zoledronate—osteoporosis	0.00363	0.00371	CcSEcCtD
Mepenzolate—Constipation—Estradiol—osteoporosis	0.00362	0.0037	CcSEcCtD
Mepenzolate—Nausea—Pamidronate—osteoporosis	0.00357	0.00365	CcSEcCtD
Mepenzolate—Dizziness—Conjugated Estrogens—osteoporosis	0.0035	0.00358	CcSEcCtD
Mepenzolate—Vomiting—Zoledronate—osteoporosis	0.00349	0.00357	CcSEcCtD
Mepenzolate—Feeling abnormal—Estradiol—osteoporosis	0.00349	0.00357	CcSEcCtD
Mepenzolate—Headache—Zoledronate—osteoporosis	0.00344	0.00352	CcSEcCtD
Mepenzolate—Vomiting—Conjugated Estrogens—osteoporosis	0.00336	0.00344	CcSEcCtD
Mepenzolate—Urticaria—Estradiol—osteoporosis	0.00336	0.00344	CcSEcCtD
Mepenzolate—Headache—Conjugated Estrogens—osteoporosis	0.00331	0.00339	CcSEcCtD
Mepenzolate—Nausea—Zoledronate—osteoporosis	0.00326	0.00334	CcSEcCtD
Mepenzolate—Nausea—Conjugated Estrogens—osteoporosis	0.00314	0.00321	CcSEcCtD
Mepenzolate—Hypersensitivity—Estradiol—osteoporosis	0.00312	0.00319	CcSEcCtD
Mepenzolate—Asthenia—Estradiol—osteoporosis	0.00304	0.00311	CcSEcCtD
Mepenzolate—Methadone—CYP19A1—osteoporosis	0.00302	0.137	CrCbGaD
Mepenzolate—Dizziness—Estradiol—osteoporosis	0.0028	0.00286	CcSEcCtD
Mepenzolate—Vomiting—Estradiol—osteoporosis	0.00269	0.00275	CcSEcCtD
Mepenzolate—Headache—Estradiol—osteoporosis	0.00265	0.00271	CcSEcCtD
Mepenzolate—Nausea—Estradiol—osteoporosis	0.00251	0.00257	CcSEcCtD
